38 related articles for article (PubMed ID: 38544952)
1. Efficacy of clarithromycin in eradicating Helicobacter pylori.
Satoh K; Kimura K; Takimoto T; Kihira K; Taniguchi Y; Saifuku K
J Gastroenterol; 1996 Nov; 31 Suppl 9():53-5. PubMed ID: 8959520
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin resistance in Helicobacter pylori: implications for therapy.
Fujioka T
J Gastroenterol; 2000; 35(1):69-70. PubMed ID: 10632546
[No Abstract] [Full Text] [Related]
3. Treatment of Helicobacter pylori infection: the past and the future.
Gisbert JP; Pajares JM
Eur J Intern Med; 2010 Oct; 21(5):357-9. PubMed ID: 20816583
[No Abstract] [Full Text] [Related]
4. Clarithromycin for treatment of Helicobacter pylori infections.
Graham DY
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S55-8. PubMed ID: 8574737
[TBL] [Abstract][Full Text] [Related]
5.
Nemidkanam V; Banlunara W; Chaichanawongsaroj N
Int J Nanomedicine; 2024; 19():1967-1983. PubMed ID: 38435753
[TBL] [Abstract][Full Text] [Related]
6. Fabrication, Optimization, and Characterization of Antibacterial Electrospun Shellac Fibers Loaded with
Krongrawa W; Limmatvapirat S; Vollrath MK; Kittakoop P; Saibua S; Limmatvapirat C
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678752
[TBL] [Abstract][Full Text] [Related]
7. Characterizing Kaempferia parviflora extracellular vesicles, a nanomedicine candidate.
Nemidkanam V; Chaichanawongsaroj N
PLoS One; 2022; 17(1):e0262884. PubMed ID: 35077499
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations.
Eleraky NE; Allam A; Hassan SB; Omar MM
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32046289
[TBL] [Abstract][Full Text] [Related]
9. Development of Microemulsions and Microemulgels for Enhancing Transdermal Delivery of Kaempferia parviflora Extract.
Rangsimawong W; Wattanasri P; Tonglairoum P; Akkaramongkolporn P; Rojanarata T; Ngawhirunpat T; Opanasopit P
AAPS PharmSciTech; 2018 Jul; 19(5):2058-2067. PubMed ID: 29687193
[TBL] [Abstract][Full Text] [Related]
10. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
11. Response to Article "
Yuliandari P; Maha MS; Panjaitan NSD
Int J Nanomedicine; 2024; 19():2993-2994. PubMed ID: 38544952
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
